Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA

University Hospital, Essen100 enrolled

Overview

Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA concerning the diagnostic yield, the quality and quantity of each biopsy needle without raising the rate of complications.

Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA performed in rigid bronchoscopy for patients with probable lung cancer diagnosis and enlarged mediastinal lymph nodes.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Lung Cancer

Interventions

EBUSPROCEDURE

19G and 22G EBUS needles are compared in a randomized prospective way in lung cancer patients with enlarged mediastinal lymph nodes.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female patients aged over 18 * Patients signed written informed consent * Mediastinal or hilar enlarged lymph nodes (\>10mm) in short axis radiological or clinical findings likely for lung cancer Exclusion Criteria: * Severe impairment of any organs, with do not enable anaesthesia * Quick \<80%, INR \>1,5, thrombocytes \<50/nl or PTT\>120sec * Other clinically relevant medical or psychological diseases, which affect the patients judgement or ability to participate in this study. * Insufficient language ability (spoken and written German)

Locations (2)

Ruhrlandklinik, University Hospital Essen

Essen, North Rhine-Westphalia, Germany

University Hospital Zürich

Zurich, Switzerland

Outcomes

Primary Outcomes

sample weight

Time frame: February 2017

Secondary Outcomes

The number of complications like bleeding, infections, pneumothorax and pain

Time frame: February 2017

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.